Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. SHSSX: which is better?

Bottom line

XLV vs SHSSX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 78% by weight.

But SHSSX is far broader, holding 155 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 0.86% — a difference of $78 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +5.9% for SHSSX.

Updated Nov 19, 2026

XLV vs SHSSX side by side

XLVSHSSX
TypeETFMutual fund
Fund familySPDR (State Street)BlackRock
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.86%
Annual cost per $10k$8$86
10-yr cost on $10k (prospectus)$103$1,061
Max front loadNone0%
12b-1 fee0.02%0%
1-yr return+14.5%+16.3%
5-yr return (annualized)+8.1%+5.9%
10-yr return (annualized)+9.8%+9.8%
Best quarter+14.5%—
Worst quarter−12.7%—
Net assets (fund)$40.6B$5.9B
Number of holdings65155
Portfolio turnover2%49%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

17 of XLV's top 25 holdings also appear in SHSSX's top 25.

Shared top holdings
HoldingXLVSHSSX
Eli Lilly & Co16.51%12.29%
Johnson & Johnson10.64%8.77%
AbbVie Inc7.74%3.94%
UnitedHealth Group Inc6.57%6.10%
Merck & Co Inc5.52%4.94%
Amgen Inc3.40%3.37%
Thermo Fisher Scientific Inc3.24%3.02%
Abbott Laboratories2.75%1.97%
Gilead Sciences Inc2.73%4.19%
Intuitive Surgical Inc2.45%1.95%
Pfizer Inc2.39%2.61%
Vertex Pharmaceuticals Inc2.19%2.74%
Danaher Corp2.09%2.00%
Stryker Corp1.89%1.15%
Elevance Health Inc1.46%1.56%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

SHSSX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

FAQ

What is the difference between XLV and SHSSX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 78% by weight. But SHSSX is far broader, holding 155 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, XLV or SHSSX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and SHSSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.